Marker Therapeutics Inc (NASDAQ: MRKR) stock closed at $4.32 on 3/26/24 after a major decline of -10.7%. Moreover, this decline was accompanied by exceptionally high trading volume at 231% of normal. The stock is unchanged during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
MRKR’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to be Value Creation neutral.
Marker Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Marker Therapeutics has a poor Power Rating of 26 and a very low Appreciation Score of 9, and the Lowest Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment